AQP4+ NMOSD

Clinical trials for AQP4+ NMOSD explained in plain language.

Never miss a new study

Get alerted when new AQP4+ NMOSD trials appear

Sign up with your email to follow new studies for AQP4+ NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Real-World watch: tracking a rare neurological disease over five years

Disease control Recruiting now

This study aims to collect long-term, real-world data on how well specific C5 inhibitor medications control relapses and affect quality of life for adults with AQP4+ NMOSD, a rare autoimmune disorder that attacks the nerves in the eyes and spinal cord. It will follow 122 particip…

Matched conditions: AQP4+ NMOSD

Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

AQP4+ NMOSD

Get alerted when new AQP4+ NMOSD trials appear

Real-World watch: tracking a rare neurological disease over five years